Compared with T2DM-non MCI, T2DM-MCI patients presented with elevated FBG and reduced serum Angiotensin-(1-7) levels (all p < 0.05; Table 1 and Figure 1B). This evidence concerns the gene AGT and type 2 diabetes mellitus.